MASIMO CORP — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that MASIMO CORP filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Jan 1, 2022 | $327.58M | Feb 16, 2022 |
| FY2021 | Oct 2, 2021 | $307.41M | Feb 16, 2022 |
| FY2021 | Jul 3, 2021 | $305.12M | Feb 16, 2022 |
| FY2021 | Apr 3, 2021 | $299.04M | Feb 16, 2022 |
| FY2020 | Jan 2, 2021 | $295.05M | Feb 23, 2021 |
| FY2021 | Sep 26, 2020 | $278.11M | Feb 16, 2022 |
| FY2021 | Jun 27, 2020 | $300.95M | Feb 16, 2022 |
| FY2021 | Mar 28, 2020 | $269.63M | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $247.51M | Feb 23, 2021 |
| FY2020 | Sep 28, 2019 | $229.01M | Feb 23, 2021 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $1.53B | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $1.40B | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | $1.28B | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $2.04B | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $1.24B | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $1.14B | Mar 1, 2023 |
Gross Profit
Revenue minus the cost of goods sold (COGS). Gross profit shows how much revenue remains to cover operating expenses, R&D, and administrative costs before calculating operating income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $945.20M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $794.30M | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | $765.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $1.06B | Feb 25, 2025 |
| FY2021 | Jan 1, 2022 | $214.90M | Feb 16, 2022 |
| FY2021 | Oct 2, 2021 | $203.66M | Feb 16, 2022 |
| FY2021 | Jul 3, 2021 | $192.91M | Feb 16, 2022 |
| FY2021 | Apr 3, 2021 | $196.88M | Feb 16, 2022 |
| FY2020 | Jan 2, 2021 | $186.93M | Feb 23, 2021 |
| FY2021 | Sep 26, 2020 | $178.93M | Feb 16, 2022 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | ($151.50M) | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | ($304.90M) | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | $81.50M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $143.50M | Feb 25, 2025 |
| FY2021 | Jan 1, 2022 | $68.26M | Feb 16, 2022 |
| FY2021 | Oct 2, 2021 | $57.77M | Feb 16, 2022 |
| FY2021 | Jul 3, 2021 | $50.24M | Feb 16, 2022 |
| FY2021 | Apr 3, 2021 | $53.38M | Feb 16, 2022 |
| FY2020 | Jan 2, 2021 | $70.67M | Feb 23, 2021 |
| FY2021 | Sep 26, 2020 | $49.41M | Feb 16, 2022 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $310.00M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $63.00M | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | $166.00M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $210.00M | Feb 25, 2025 |
| FY2021 | Jan 1, 2022 | $77.41M | Feb 16, 2022 |
| FY2021 | Oct 2, 2021 | $67.61M | Feb 16, 2022 |
| FY2021 | Jul 3, 2021 | $65.14M | Feb 16, 2022 |
| FY2021 | Apr 3, 2021 | $65.66M | Feb 16, 2022 |
| FY2020 | Jan 2, 2021 | $64.90M | Feb 23, 2021 |
| FY2021 | Sep 26, 2020 | $59.70M | Feb 16, 2022 |
R&D Expense
Spending on research and development activities — developing new products, improving existing ones, or conducting basic research. High R&D relative to revenue is common in technology and pharmaceutical companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $126.40M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $182.20M | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | $130.50M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $191.40M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $137.20M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $118.70M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $93.30M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $81.01M | Feb 23, 2021 |
| FY2019 | Dec 30, 2017 | $65.23M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $57.69M | Feb 26, 2019 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $506.00M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $548.60M | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | $451.30M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $657.40M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $395.40M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $369.00M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $314.66M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $285.42M | Feb 23, 2021 |
| FY2019 | Dec 30, 2017 | $273.01M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $254.71M | Feb 26, 2019 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $217.80M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $196.40M | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | $94.10M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $29.40M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $264.60M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $211.10M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $221.64M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $239.53M | Feb 23, 2021 |
| FY2019 | Dec 30, 2017 | $56.06M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $419.13M | Feb 26, 2019 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $19.40M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $21.10M | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | $38.40M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $52.80M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $25.50M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $72.50M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $68.38M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $17.13M | Feb 23, 2021 |
| FY2019 | Dec 30, 2017 | $43.68M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $19.71M | Feb 26, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $1.70B | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $2.63B | Feb 27, 2026 |
| FY2024 | Dec 30, 2023 | $3.04B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $3.21B | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $1.89B | Mar 1, 2023 |
| FY2021 | Jan 2, 2021 | $1.71B | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $1.40B | Feb 23, 2021 |
| FY2019 | Dec 29, 2018 | $1.15B | Feb 19, 2020 |
| FY2018 | Dec 30, 2017 | $905.44M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $820.53M | Feb 28, 2018 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $977.70M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $1.57B | Feb 27, 2026 |
| FY2024 | Dec 30, 2023 | $1.68B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.87B | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $336.80M | Mar 1, 2023 |
| FY2021 | Jan 2, 2021 | $304.91M | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $228.25M | Feb 23, 2021 |
| FY2019 | Dec 29, 2018 | $185.75M | Feb 19, 2020 |
| FY2018 | Dec 30, 2017 | $181.41M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $260.29M | Feb 28, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $721.20M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $1.05B | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | $1.36B | Feb 27, 2026 |
| FY2025 | Dec 31, 2022 | $1.34B | Feb 27, 2026 |
| FY2024 | Jan 1, 2022 | $1.55B | Feb 25, 2025 |
| FY2023 | Jan 2, 2021 | $1.41B | Feb 28, 2024 |
| FY2020 | Dec 28, 2019 | $1.17B | Feb 23, 2021 |
| FY2019 | Dec 29, 2018 | $969.07M | Feb 19, 2020 |
| FY2018 | Dec 30, 2017 | $724.03M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $560.24M | Feb 28, 2018 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $101.00M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $96.70M | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | $98.60M | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | $445.40M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $100.30M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $103.20M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $22.35M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $23.30M | Feb 23, 2021 |
| FY2019 | Dec 30, 2017 | $20.62M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $19.78M | Feb 26, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $1.34B | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $1.49B | Feb 27, 2026 |
| FY2024 | Dec 30, 2023 | $1.80B | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | $1.71B | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | $1.57B | Mar 1, 2023 |
| FY2021 | Jan 2, 2021 | $1.34B | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | $1.10B | Feb 23, 2021 |
| FY2019 | Dec 29, 2018 | $931.07M | Feb 19, 2020 |
| FY2018 | Dec 30, 2017 | $737.96M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | $589.23M | Feb 28, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $152.30M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | $123.60M | Feb 27, 2026 |
| FY2024 | Dec 30, 2023 | $163.00M | Feb 25, 2025 |
| FY2024 | Dec 31, 2022 | $202.90M | Feb 25, 2025 |
| FY2023 | Jan 1, 2022 | $745.30M | Feb 28, 2024 |
| FY2022 | Jan 2, 2021 | $641.40M | Mar 1, 2023 |
| FY2021 | Dec 28, 2019 | $567.69M | Feb 16, 2022 |
| FY2020 | Dec 29, 2018 | $552.49M | Feb 23, 2021 |
| FY2019 | Dec 30, 2017 | $315.30M | Feb 19, 2020 |
| FY2018 | Dec 31, 2016 | $305.97M | Feb 26, 2019 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | $524.30M | Feb 27, 2026 |
| FY2024 | Dec 28, 2024 | $765.20M | Feb 25, 2025 |
| FY2023 | Dec 30, 2023 | $906.00M | Feb 28, 2024 |
| FY2022 | Dec 31, 2022 | $956.70M | Mar 1, 2023 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | (2) | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | (5) | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 25, 2025 |
| FY2021 | Jan 1, 2022 | 1 | Feb 16, 2022 |
| FY2021 | Oct 2, 2021 | 1 | Feb 16, 2022 |
| FY2021 | Jul 3, 2021 | 0 | Feb 16, 2022 |
| FY2021 | Apr 3, 2021 | 0 | Feb 16, 2022 |
| FY2020 | Jan 2, 2021 | 1 | Feb 23, 2021 |
| FY2021 | Sep 26, 2020 | 0 | Feb 16, 2022 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | (2) | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | (5) | Feb 27, 2026 |
| FY2025 | Dec 30, 2023 | 1 | Feb 27, 2026 |
| FY2024 | Dec 31, 2022 | 2 | Feb 25, 2025 |
| FY2021 | Jan 1, 2022 | 1 | Feb 16, 2022 |
| FY2021 | Oct 2, 2021 | 1 | Feb 16, 2022 |
| FY2021 | Jul 3, 2021 | 0 | Feb 16, 2022 |
| FY2021 | Apr 3, 2021 | 0 | Feb 16, 2022 |
| FY2020 | Jan 2, 2021 | 1 | Feb 23, 2021 |
| FY2021 | Sep 26, 2020 | 0 | Feb 16, 2022 |
Shares Outstanding
Total common shares issued and held by all shareholders, excluding treasury shares. Combined with market price gives market capitalization.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Jan 3, 2026 | 52.10M | Feb 27, 2026 |
| FY2025 | Dec 28, 2024 | 53.60M | Feb 27, 2026 |
| FY2024 | Dec 30, 2023 | 52.80M | Feb 25, 2025 |
| FY2023 | Dec 31, 2022 | 52.50M | Feb 28, 2024 |
| FY2022 | Jan 1, 2022 | 55.30M | Mar 1, 2023 |
| FY2021 | Jan 2, 2021 | 55.25M | Feb 16, 2022 |
| FY2020 | Dec 28, 2019 | 53.70M | Feb 23, 2021 |
| FY2019 | Dec 29, 2018 | 53.09M | Feb 19, 2020 |
| FY2018 | Dec 30, 2017 | 51.64M | Feb 26, 2019 |
| FY2017 | Dec 31, 2016 | 51.64M | Feb 28, 2018 |